Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Madison. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Madison location
Access macular degeneration specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
Check if you qualify for this macular degeneration clinical trial in Madison, MS
No-Cost Study Care
Local to Madison
Convenient for MS residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
EYE-TIE-201 is a 2-part study to investigate the safety and effectiveness of a new drug being developed called EYE201. All participants in the study will receive a total of 3 injections of EYE201 into the study eye, spaced at 4 weeks apart. In the first part, termed the multiple ascending dose (MAD) portion of study, the safety of EYE201 will be assessed at increasing doses in branch retinal vein occlusion (BRVO) participants. Approximately 12 participants will be entered in this part of the s
Sponsor: EyeBiotech Ltd.
Yes, this clinical trial (NCT06664502) has an active research site in Madison, MS that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for macular degeneration treatment options in Madison, MS, this clinical trial (NCT06664502) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Madison research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all macular degeneration clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in Madison — not just this study.
Browse Rheumatoid Arthritis Trials in Madison →